Circulars 2023

Circular 18 of 2023 – Fees for Laboratory Analysis Of Complementary Medicines

Circular 20 of 2023 – Fees schedule

Circular 19 of 2023_ Implementation Plan for Re-Registration of Human Allopathic Medicines _Proposed Fees

Publication of cancelled Wholesale Dealer’s Permits, Premises Licences and Persons’ Licences

Circular 12 of 2023 : Regulatory Alert Regarding the Selling of Specially Restricted Preparations and Thalidomide

Circular 13 of 2023 Suspension of the Small Business Support Function Till Further Notice

Circular 25 of 2022- Notification of issuance of revised registration certificates for variations at re-registration

Circular 11 Of 2023 – Follow-Up Plan for Registration of Human Allopathic Medicines

Circular 14 of 2022 – Implementation Plan for Re-Registration of Human Allopathic Medicines

Circular 6 of 2023 – Instruction to quarantine all Pholcodine-containing products

CIRCULAR 5 OF 2023 -INSTRUCTION TO QUARANTINE TETRACYCLINE HYDROCHLORIDE OPHTHALMIC OINTMENT USP 1% MANUFACTURED BY GALENTIC PHARMA (INDIA) PVT, LTD, R-673, T.T.C. MIDC RABALE, THANE-BELAPUR ROAD, NAVI MUMBAI-400701, MAHARASHTRA, INDIA

Circular 4 of 2023 – Change of Value Added Tax (TAX) Rate from 14.5% to 15%

Circular 02 of 2023- Renewal of Premises and Persons Licences

Circular 01 of 2023- Renewal of Permits and Persons licences for Wholesale dealers, Sales Representative and Pharmacy Technicians